Global Tagrisso (Osimertinib) Market Research Report 2022

Table Of Contents

1 Tagrisso (Osimertinib) Market Overview

1.1 Product Overview and Scope of Tagrisso (Osimertinib) 1.2 Tagrisso (Osimertinib) Segment by Type 1.2.1 Global Tagrisso (Osimertinib) Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 40 mg 1.2.3 80 mg 1.3 Tagrisso (Osimertinib) Segment by Application 1.3.1 Global Tagrisso (Osimertinib) Sales Comparison by Application: (2022-2028) 1.3.2 Locally Advanced NSCLC 1.3.3 Metastatic NSCLC 1.3.4 Other 1.4 Global Tagrisso (Osimertinib) Market Size Estimates and Forecasts 1.4.1 Global Tagrisso (Osimertinib) Revenue 2017-2028 1.4.2 Global Tagrisso (Osimertinib) Sales 2017-2028 1.4.3 Tagrisso (Osimertinib) Market Size by Region: 2017 Versus 2021 Versus 20282 Tagrisso (Osimertinib) Market Competition by Manufacturers 2.1 Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2017-2022) 2.2 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Tagrisso (Osimertinib) Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Tagrisso (Osimertinib) Manufacturing Sites, Area Served, Product Type 2.5 Tagrisso (Osimertinib) Market Competitive Situation and Trends 2.5.1 Tagrisso (Osimertinib) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Tagrisso (Osimertinib) Players Market Share by Revenue 2.5.3 Global Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans3 Tagrisso (Osimertinib) Retrospective Market Scenario by Region 3.1 Global Tagrisso (Osimertinib) Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Tagrisso (Osimertinib) Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Tagrisso (Osimertinib) Market Facts & Figures by Country 3.3.1 North America Tagrisso (Osimertinib) Sales by Country 3.3.2 North America Tagrisso (Osimertinib) Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Tagrisso (Osimertinib) Market Facts & Figures by Country 3.4.1 Europe Tagrisso (Osimertinib) Sales by Country 3.4.2 Europe Tagrisso (Osimertinib) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Tagrisso (Osimertinib) Market Facts & Figures by Region 3.5.1 Asia Pacific Tagrisso (Osimertinib) Sales by Region 3.5.2 Asia Pacific Tagrisso (Osimertinib) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Tagrisso (Osimertinib) Market Facts & Figures by Country 3.6.1 Latin America Tagrisso (Osimertinib) Sales by Country 3.6.2 Latin America Tagrisso (Osimertinib) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Tagrisso (Osimertinib) Market Facts & Figures by Country 3.7.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Country 3.7.2 Middle East and Africa Tagrisso (Osimertinib) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE4 Global Tagrisso (Osimertinib) Historic Market Analysis by Type 4.1 Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022) 4.2 Global Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2022) 4.3 Global Tagrisso (Osimertinib) Price by Type (2017-2022)5 Global Tagrisso (Osimertinib) Historic Market Analysis by Application 5.1 Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022) 5.2 Global Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2022) 5.3 Global Tagrisso (Osimertinib) Price by Application (2017-2022)6 Key Companies Profiled 6.1 AstraZeneca 6.1.1 AstraZeneca Corporation Information 6.1.2 AstraZeneca Description and Business Overview 6.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022) 6.1.4 AstraZeneca Tagrisso (Osimertinib) Product Portfolio 6.1.5 AstraZeneca Recent Developments/Updates 6.2 Incepta Pharmaceuticals Ltd 6.2.1 Incepta Pharmaceuticals Ltd Corporation Information 6.2.2 Incepta Pharmaceuticals Ltd Description and Business Overview 6.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Portfolio 6.2.5 Incepta Pharmaceuticals Ltd Recent Developments/Updates 6.3 Lonza AG 6.3.1 Lonza AG Corporation Information 6.3.2 Lonza AG Description and Business Overview 6.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Lonza AG Tagrisso (Osimertinib) Product Portfolio 6.3.5 Lonza AG Recent Developments/Updates 6.4 Everest Pharmaceuticals 6.4.1 Everest Pharmaceuticals Corporation Information 6.4.2 Everest Pharmaceuticals Description and Business Overview 6.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Portfolio 6.4.5 Everest Pharmaceuticals Recent Developments/Updates 6.5 Beacon Pharmaceuticals Limited 6.5.1 Beacon Pharmaceuticals Limited Corporation Information 6.5.2 Beacon Pharmaceuticals Limited Description and Business Overview 6.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Portfolio 6.5.5 Beacon Pharmaceuticals Limited Recent Developments/Updates 6.6 Drug International Limited 6.6.1 Drug International Limited Corporation Information 6.6.2 Drug International Limited Description and Business Overview 6.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Drug International Limited Tagrisso (Osimertinib) Product Portfolio 6.6.5 Drug International Limited Recent Developments/Updates7 Tagrisso (Osimertinib) Manufacturing Cost Analysis 7.1 Tagrisso (Osimertinib) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Tagrisso (Osimertinib) 7.4 Tagrisso (Osimertinib) Industrial Chain Analysis8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Tagrisso (Osimertinib) Distributors List 8.3 Tagrisso (Osimertinib) Customers9 Tagrisso (Osimertinib) Market Dynamics 9.1 Tagrisso (Osimertinib) Industry Trends 9.2 Tagrisso (Osimertinib) Market Drivers 9.3 Tagrisso (Osimertinib) Market Challenges 9.4 Tagrisso (Osimertinib) Market Restraints10 Global Market Forecast 10.1 Tagrisso (Osimertinib) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Tagrisso (Osimertinib) by Type (2023-2028) 10.2 Tagrisso (Osimertinib) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Tagrisso (Osimertinib) by Application (2023-2028) 10.3 Tagrisso (Osimertinib) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Tagrisso (Osimertinib) by Region (2023-2028)11 Research Finding and Conclusion12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer